Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
14.93
+0.38 (2.61%)
Oct 19, 2026, 10:06 AM EDT - Market open
Greenwich LifeSciences Employees
As of December 31, 2024, Greenwich LifeSciences had 8 total employees, including 4 full-time and 4 part-time employees. The number of employees increased by 1 or 14.29% compared to the previous year. That makes Greenwich LifeSciences the 40,711th largest employer in the world and 6,162nd in the United States.
Employees
8
Change (1Y)
1
Growth (1Y)
14.29%
Revenue / Employee
n/a
Profits / Employee
-$2,808,826
Market Cap
219.15M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 8 | 1 | 14.29% | 4 | 4 |
| Dec 31, 2023 | 7 | 1 | 16.67% | 3 | 4 |
| Dec 31, 2022 | 6 | 0 | - | 3 | 3 |
| Dec 31, 2021 | 6 | 3 | 100.00% | 3 | 3 |
| Dec 31, 2020 | 3 | - | - | 1 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Protalix BioTherapeutics | 226 |
| Fate Therapeutics | 161 |
| Alector | 103 |
| Keros Therapeutics | 92 |
| BridgeBio Oncology Therapeutics | 88 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 63 |
GLSI News
- 7 weeks ago - 20 stocks likely to lose money even if the bull market continues - Market Watch
- 2 months ago - Greenwich LifeSciences Quarterly report: Q2 2026 - Filings
- 2 months ago - Greenwich LifeSciences extends lock-up of directors and officers to 2027 - TheFly
- 2 months ago - Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027 - GlobeNewsWire
- 2 months ago - Greenwich receives regulatory approval to expand Flamingo-01 in the U.K. - TheFly
- 2 months ago - Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom - GlobeNewsWire
- 2 months ago - Greenwich LifeSciences price target raised to $69 from $50 at H.C. Wainwright - TheFly
- 3 months ago - Greenwich LifeSciences provides clinical and financial updates on Flamingo-01 - TheFly